Key facts
- This page summarizes David L. Copeland's Form 4 filing for HARTE HANKS INC (HHS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2023, 14:52.
David L. Copeland - 17 Aug 2023 Form 4 Insider Report for HARTE HANKS INC (HHS)
- Reporting relationship
- Director
- Issuer ticker
- HHS
- Reported as of
- 17 Aug 2023
- Net transaction value
- +$89,999
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2023, 14:52:42 UTC
- Prior SEC filing
- 27 Apr 2023
- Next SEC filing
- 04 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Laurilee Kearnes, Attorney-in-Fact for David L. Copeland
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David L. Copeland filed Form 4 for HARTE HANKS INC (HHS) on 21 Aug 2023.
Change
- Previous filing in this sequence was filed on 27 Apr 2023.
- Current net transaction value: +$89,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HHS
transaction
Common Stock
Award
- Transaction value
- $89,999
- Shares
- +16,216
- Change %
- +17%
- Price
- $5.55
- Shares after
- 110,337
- Date
- 17 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On August 17, 2023 the reporting person was granted 16,216 Restricted Stock Units, vesting in full on the first anniversary of the grant date.